STOCK TITAN

CVS HEALTH CORPORATION - CVS STOCK NEWS

Welcome to our dedicated page for CVS HEALTH CORPORATION news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on CVS HEALTH CORPORATION stock.

CVS Health Corporation (NYSE: CVS) is an American healthcare conglomerate that encompasses CVS Pharmacy, a widespread retail pharmacy chain, CVS Caremark, a premier pharmacy benefits manager (PBM), and Aetna, a leading health insurance provider. With over 9,000 retail locations across the U.S., CVS Health offers a diverse range of healthcare services aimed at enhancing accessibility and affordability.

Operations and Services

CVS Health's core activities revolve around its retail pharmacy operations, which include prescription services and an array of health and wellness products. It processes approximately 2 billion adjusted claims annually through CVS Caremark, ensuring efficient PBM services. Aetna, serving about 26 million medical members, complements CVS with comprehensive health insurance plans.

Recent Developments

In recent news, CVS Health has achieved significant milestones:

  • Financial Results: The company reported strong fourth-quarter and full-year financial results for 2023, reflecting its robust position in the healthcare market.
  • Affordable Housing Initiatives: CVS Health has invested nearly $35 million in equity investments to develop affordable housing in Hawaii, addressing urgent community needs post-natural disasters.
  • Medicaid Services: Aetna Better Health of Michigan, part of CVS Health, has been recommended to continue serving Medicaid and CHIP beneficiaries under Michigan’s new Comprehensive Health Care Program (CHCP).

Strategic Acquisitions

CVS Health's acquisition of Oak Street Health adds primary care services to its offering, fostering synergies across its business lines. This strategic move aligns with its mission to provide seamless healthcare solutions, emphasizing convenience and comprehensive care.

Community Impact

CVS Health is committed to enhancing community health through local presence and digital channels. Its investments in affordable housing and educational programs in Hawaii exemplify its dedication to addressing social determinants of health.

Upcoming Events

The company will hold a conference call on May 1st, 2024, to discuss the first-quarter financial results of 2024, offering insights into its ongoing strategies and performance.

With over 300,000 dedicated professionals, including 40,000+ healthcare providers, CVS Health continues to be a trusted partner in health, improving lives with every significant moment of care.

Rhea-AI Summary

CVS Health reported full-year 2020 total revenues of $268.7 billion, a 4.6% increase from 2019. GAAP diluted EPS for 2020 was $5.47, while adjusted EPS stood at $7.50. COVID-19 significantly impacted operations, with net income decreasing 44.1% in Q4 compared to 2019, primarily due to a $674 million loss on early debt extinguishment. The company anticipates 2021 GAAP diluted EPS between $6.06 and $6.22. CVS has administered 15 million COVID-19 tests and 3 million vaccines, demonstrating its role in pandemic response.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.96%
Tags
none
-
Rhea-AI Summary

CVS Health is set to begin administering COVID-19 vaccines at 17 pharmacy locations in South Carolina on February 11. This limited rollout will provide approximately 15,300 doses sourced from a federal pharmacy partnership program. Appointments can be booked starting February 9. The initiative is part of a larger multi-state rollout, including approximately 335 locations across various states, with a goal to eventually administer 20-25 million shots per month. CVS Health continues to expand vaccine accessibility while supporting long-term care facilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
covid-19
-
Rhea-AI Summary

CVS Health is set to administer COVID-19 vaccines starting February 11, 2021, at 28 pharmacy locations in Virginia. Approximately 26,000 doses will be available through the federal pharmacy partnership program. Appointments can be booked beginning February 9. This vaccine rollout is part of an initial plan covering 11 states, with CVS capable of administering 20-25 million shots monthly. CVS also advances vaccination efforts at over 870 long-term care facilities across Virginia, aiming for complete first doses by mid-February. The company highlights its community presence as key to effective vaccination.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
covid-19
Rhea-AI Summary

CVS Health is set to begin administering COVID-19 vaccines at 32 pharmacy locations across New York starting February 11, 2021. Appointments can be booked from February 9, with a total supply of approximately 20,600 doses. The initiative is part of a broader 11-state rollout and aims to expand as vaccine supplies increase. CVS focuses on community presence for efficient vaccine distribution. The company is also vaccinating residents at over 1,200 long-term care facilities in New York, with first doses expected to be completed by mid-February.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
covid-19
-
Rhea-AI Summary

CVS Health will begin administering COVID-19 vaccines on February 11 at four pharmacy locations in Rhode Island. Appointments can be booked starting February 9 with 3,400 doses available. This initiative is part of a broader rollout across 11 states and aims to leverage CVS's community presence for vaccine distribution. The company plans to expand as more doses become available, with a capacity to administer up to 25 million shots monthly. CVS is also vaccinating residents in over 200 long-term care facilities in Rhode Island.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
covid-19
-
Rhea-AI Summary

CVS Health will begin administering COVID-19 vaccines at 70 pharmacy locations in Texas starting February 11, 2021. Approximately 38,000 doses will be available initially, with appointments open for booking on February 9. The rollout is part of an 11-state initiative, with plans to expand as vaccine supply increases. CVS aims to provide 20-25 million shots monthly nationwide, emphasizing community access to vaccines. Additionally, CVS is progressing with vaccination efforts in over 2,000 long-term care facilities in Texas, aiming to complete first doses by mid-February.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
covid-19
Rhea-AI Summary

CVS Health is set to administer COVID-19 vaccines starting on February 11 at 18 locations in Massachusetts. This initiative is part of a broader rollout across 11 states, with approximately 21,600 doses available. Appointments for vaccinations can be booked from February 9. CVS aims to administer 20-25 million shots monthly as supply increases. The company is also vaccinating staff and residents at over 1,900 long-term care facilities in the state, with first doses expected to be completed by mid-February.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
covid-19
-
Rhea-AI Summary

CVS Health will start administering COVID-19 vaccines at 27 pharmacy locations in New Jersey on February 11, 2021. Appointments can be booked from February 9, with approximately 19,900 doses available for the initial rollout. The company is part of a broader initiative to provide vaccines across 11 states, aiming to eventually administer 20-25 million shots per month. Vaccines will be offered to eligible individuals as per state guidelines, with a focus on safety and community presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
covid-19
-
Rhea-AI Summary

CVS Health (NYSE: CVS) announced it will start administering COVID-19 vaccines at seven Longs Drugs locations in Hawaii from February 11, 2021. Approximately 4,400 doses will be available through the federal pharmacy partnership program. Appointments can be booked starting February 9. CVS plans to eventually offer vaccines across 335 locations in eleven states, aiming to administer 20-25 million vaccines monthly. CVS is also progressing in vaccinating residents at over 45 long-term care facilities in Hawaii.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
covid-19
Rhea-AI Summary

CVS Health announced that starting February 11, it will administer COVID-19 vaccines at 18 locations in Maryland. This initiative is part of a broader rollout across 11 states, with an initial supply of approximately 11,000 doses. Appointments can be booked from February 9, and only eligible individuals who meet state criteria can receive vaccinations. CVS aims to expand its services as more vaccines become available, with a capacity to administer 20-25 million shots monthly. The company also continues vaccination efforts in over 1,700 long-term care facilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
covid-19

FAQ

What is the current stock price of CVS HEALTH CORPORATION (CVS)?

The current stock price of CVS HEALTH CORPORATION (CVS) is $56.46 as of October 31, 2024.

What is the market cap of CVS HEALTH CORPORATION (CVS)?

The market cap of CVS HEALTH CORPORATION (CVS) is approximately 72.9B.

What does CVS Health Corporation do?

CVS Health Corporation is a healthcare conglomerate that includes a retail pharmacy chain, a pharmacy benefits manager, and a health insurance provider.

How many stores does CVS Health operate?

CVS Health operates over 9,000 retail pharmacy stores across the United States.

What recent acquisitions have CVS Health made?

CVS Health recently acquired Oak Street Health, adding primary care services to its existing healthcare offerings.

What is CVS Caremark?

CVS Caremark is the pharmacy benefits manager (PBM) division of CVS Health, processing about 2 billion adjusted claims annually.

What services does Aetna provide?

Aetna, part of CVS Health, provides a range of health insurance products, serving approximately 26 million medical members.

What community initiatives is CVS Health involved in?

CVS Health invests in affordable housing and educational programs, particularly in areas like Hawaii to support community health and wellbeing.

What is the financial outlook for CVS Health in 2024?

CVS Health revised its full-year 2024 GAAP diluted EPS guidance to at least $5.64 and adjusted EPS guidance to at least $7.00, reflecting continued medical cost trends.

When will CVS Health discuss its first-quarter results of 2024?

CVS Health will hold a conference call on May 1st, 2024, to discuss its first-quarter financial results.

How does CVS Health support Medicaid and CHIP beneficiaries?

Through Aetna Better Health, CVS Health supports Medicaid and CHIP beneficiaries by providing coordinated health care services, recently recommended to continue service in Michigan.

How does CVS Health improve access to healthcare?

CVS Health improves healthcare access through its extensive retail network, digital channels, and comprehensive health insurance plans, addressing various health and wellness needs.

CVS HEALTH CORPORATION

NYSE:CVS

CVS Rankings

CVS Stock Data

72.91B
1.26B
0.12%
83.05%
1.65%
Healthcare Plans
Retail-drug Stores and Proprietary Stores
Link
United States of America
WOONSOCKET